Furthermore, in patients with metabolic (dysfunction)-associated Steatohepatitis (MASH), high expression of hepatic AKR1B10 is linked to reduced hepatic retinoid levels, exacerbating the progression from MASH to Hepatocellular Carcinoma (HCC) (58). This evidence concerns the gene AKR1B10 and hepatocellular carcinoma.